By asianet
– Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics – Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company in Japan, is pleased to announce that the U.S. Food and Drug Administration (FDA) has recently accepted NMP’s Investigational New Drug (IND) application to initiate a first-in-human phase I clinical study of “NMK89 … Continued
By asianet
Following our communication last week “MedAlliance to be acquired by Cordis”, MedAlliance is pleased to make the following announcement: Photo – https://mma.prnewswire.com/media/1928464/MedAlliance_Image.jpg Logo – https://mma.prnewswire.com/media/1196864/MedAlliance_Logo.jpg SELUTION SLR(TM), MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial. This is the first sustained limus release coronary drug … Continued
By asianet
– Preclinical data showing how ERA(TM), eTurna(TM) technologies turbocharge T-cell therapies presented at New Frontiers of RNA Nanotherapeutics meeting today – ERA(TM) boosts CAR T-cell efficacy by overcoming T-cell exhaustion that inhibits cancer cures – eTurna(TM) delivery platform delivers more healthy, functional T-cells than electroporation, without the safety risks of viral vectors – Use of … Continued
By asianet
Scientists at deCODE genetics, a subsidiary of Amgen, publish today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were identified, including rare, protective loss-of-function variants that point to potential drug targets. Plasma proteomic analyses provided further insight into the pathogenesis of NAFLD NAFLD … Continued
By asianet
Concept Medical Inc. [https://www.conceptmedical.com/] announces the successful completion of the SIRONA – World’s first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA [https://www.conceptmedical.com/product/magic-touch-pta/] – Concept Medical Inc.) V/S Paclitaxel DCB angioplasty for the treatment of peripheral artery disease in the femoropopliteal vessel segment. The prospective, multi-center, … Continued
By asianet
Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention. Osteoporosis is a bone disease that affects some 500 million people worldwide and is a major cause of pain, disability and loss of independence in older … Continued
By asianet
Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was scheduled for completion in October 2022, was successfully completed in full compliance with the planned timeline. Alfasigma is one of the leading multinational pharmaceutical companies with over … Continued
By asianet
*CHP’s AdCheck independent advertising advisory service creates content management and communication efficiencies for members Veeva Systems(https://www.veeva.com/) (NYSE: VEEV) today announced that AdCheck(https://www.chpaustralia.com.au/AdCheck), an independent advertising advisory service provided by Consumer Healthcare Products (CHP) Australia(https://www.chpaustralia.com.au/Home), is leveraging Veeva Vault PromoMats to create a single hub of content for its clients’ Therapeutic Goods Advertising Code (TGAC) applications. “Veeva … Continued
By asianet
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a first booster dose at least six months after completion of primary … Continued
By asianet
Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of $200M, regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029 for a total consideration of up to $1.135 … Continued